ACADIA Pharmaceuticals
ACAD
#3223
Rank
S$5.87 B
Marketcap
S$34.70
Share price
-2.48%
Change (1 day)
37.92%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$0.53 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's total liabilities are S$0.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

ACADIA Pharmaceuticals - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$0.61 B47.62%
2023-12-31S$0.41 B66.75%
2022-12-31S$0.25 B16.71%
2021-12-31S$0.21 B4.57%
2020-12-31S$0.20 B81.67%
2019-12-31S$0.11 B35.7%
2018-12-31S$83.5 M26.84%
2017-12-31S$65.83 M6.42%
2016-12-31S$61.86 M97.58%
2015-12-31S$31.3 M48.38%
2014-12-31S$21.1 M138.36%
2013-12-31S$8.85 M-69.33%
2012-12-31S$28.86 M154.69%
2011-12-31S$11.33 M1.07%
2010-12-31S$11.21 M-78.74%
2009-12-31S$52.73 M215.6%
2008-12-31S$16.71 M-43.76%
2007-12-31S$29.71 M-13.43%
2006-12-31S$34.32 M-10.89%
2005-12-31S$38.51 M143.79%
2004-12-31S$15.8 M-88.98%
2003-12-31S$0.14 B47.21%
2002-12-31S$97.36 M1183.76%
2001-12-31S$7.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Vanda Pharmaceuticals
VNDA
S$0.17 B-67.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$149.95 B 27,865.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$118.11 B 21,927.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$147.23 B 27,358.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$101.52 B 18,833.30%๐Ÿ‡บ๐Ÿ‡ธ USA